Cardioprotective potential of Lavandula stoechas against isoprenaline-induced myocardial necrosis in rats

Abstract

This study assessed Lavandula stoechas flower extract's impact on Isoprenaline-induced myocardial necrosis in rats. Five groups of five rats each were used. Group I received 1 ml/kg normal saline orally for 13 days, Group II received 10 ml/kg normal saline orally, Group III received 200 mg/kg Lavandula stoechas extract orally, Group IV received 400 mg/kg Lavandula stoechas extract orally, and Group V received 10 mg/kg Metoprolol orally. On days 14 and 15, Group I received 0.5 ml/kg subcutaneous normal saline, and Groups II to V received 85 mg/kg Isoprenaline subcutaneously. On day 16, rats were weighed, and cardiac blood samples were collected. Serum was analyzed for total protein, triglycerides, and cardiac enzymes (cardiac injury markers). Rats were sacrificed, and heart tissues were histologically examined.

Results showed significant serum marker enzyme reductions (p < 0.01) in Lavandula stoechas-treated rats. Total protein and triglyceride levels (p < 0.01) decreased, and heart weight-to-body weight ratio (p < 0.05) decreased in Lavandula stoechas-treated rats. Histopathology confirmed the extract's protective effect.

In conclusion, Lavandula stoechas flower extract offers protection against Isoprenaline-induced myocardial infarction in rats.

Keywords

Lavandula stoechas / Myocardial infarction / Isoprenaline / Ethanol extract

References

[1] Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Publ Health. 2021 Dec;21(1):1–2.

[2] World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds; 2021. Accessed October 17, 2021.

[3] Narayanan G, Prabhu K, Chaudhury AB, et al. Cardioprotective role of partharishtam on isopreterenol induced myocardial infarction in animal model. Phcog J. 2021; 13(2).

[4] Mechanic OJ, Gavin M, Grossman SA, Ziegler K. Ziegler K. Acute Myocardial Infarction (Nursing). StatPearls; 2021 Mar 9 [Internet].

[5] Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017 May 25; 376(21):2053–2064.

[6] Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017 Jan 14; 389(10065):197–210.

[7] Zaafan MA, Zaki HF, El-Brairy AI, Kenawy SA. Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats. Bull Fac Pharm. 2013 Jun 1;51(1):35–41. Cairo University.

[8] Morris Jason, Dunham Alexis. Metoprolol. Treasure Island (FL): StatPearls Publishing; 2018.

[9] Gaire BP. Herbal medicine in ischemic stroke: challenges and prospective. Chin J Integr Med. 2018 Apr;24(4):243–246.

[10] Siddiqui MA, Khalid M, Akhtar J, et al. Lavandula stoechas (Ustukhuddus): a miracle plant. J Innov Pharm. 2016; 3: 96- 102.

[11] Siddiqui A, Afrin Z, Jafri MA. An updated review on Ustukhudoos plant. J drug deliv ther. 2018 Sep 6;8(5):88–91.

[12] Rona G, Kahn DS, Chappel CI. Study on the healing of cardiac necrosis in the rat. Am J Pathol. 1961 Oct;39(4):473.

[13] Naik SR, Panda VS. Cardioprotective activity of polyherbal extracts in experimental myocardial necrosis in rodents: an evidence of antioxidant activity. J Compl Integr Med. 2008 Dec 23;5(1):1–20.

[14] Murugesan M, Ragunath M, Nadanasabapathy S, Revathi R, Manju V. Protective role of fenugreek on isoproterenol induced myocardial infarction in rats. Int Res J Pharm. 2012; 3 (2): 211- 216.

[15] Firoz M, Bharatesh K, Nilesh P, Vijay G, Tabassum S, Nilofar N. Cardioprotective activity of ethanolic extract of Callistemon lanceolatus leaves on doxorubicininduced cardiomyopathy in rats. Bangladesh J Pharmacol. 2011 Aug 10;6(1):38–45.

[16] Rona G. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol. 1959; 67: 443- 455.

[17] Panda VS, Naik SR. Cardioprotective activity of Ginkgo biloba phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol. 2008 Aug 5;60(4-5):397–404.

[18] Banerjee A. Coronary artery disease and its problem in management. J Indian Med Assoc. 2001; 99: 474- 475.

[19] Milano CA, Allen LF, Rockman HA, et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science. 1994 Apr 22;264(5158): 582–586.

[20] Agrawal VK, Basannar DR, Singh RP, Dutt M, Abraham D, Mustafa MS. Coronary risk factors in a rural community. Indian J Publ Health. 2006 Jan 1;50(1):19.

[21] Suchalatha S, shyamaladevi CS. Protectiveeffect of terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian J Exp Biol. 2004; 42: 174- 178.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).